Rippin, Gerd https://orcid.org/0000-0001-6293-8465
Ballarini, Nicolás
Sanz, Héctor
Largent, Joan
Quinten, Chantal
Pignatti, Francesco
Funding for this research was provided by:
European Medicines Agency (EMA/2017/09/PE, Lot 4, EMA/2017/09/PE, Lot 4, EMA/2017/09/PE, Lot 4, EMA/2017/09/PE, Lot 4)
Article History
Accepted: 21 June 2022
First Online: 27 July 2022
Declarations
:
: This work was funded by the European Medicines Agency (EMA/2017/09/PE, Lot 4).
: The authors declare that there are no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: The main author (GR) conducted the literature research and drafted the first version of the publication. Contributing authors (NB, HS, JL, CQ and FP) revised and added to the first and subsequent versions. Each author had participated sufficiently in the work to take responsibility of portions of the content. All authors read and approved the final manuscript.
: The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agency/agencies or organizations with which the authors are employed/affiliated.